提高生物拮抗菌对果实采后病害的生防效力研究

摘要 　　"随着人们对身体健康和环境污染的日益重视，化学农药作为控制果实采后病害的主要方法受到了很大限制，科学研究者不得不寻求更加安全有效的防治果实采后病害的新方法。生物防治以其对环境和人类健康不造成危害的优点而逐渐受到人们的青睐。然而，由于生物防治是以活菌为基础，有其局限性和时效性，单独使用拮抗菌很难达到化学药剂完全控制果实采后病害的效果，因此，提高拮抗菌的生防效力成为当今生物防治领域的研究重点。本文主要研究了拮抗菌与不同外源物质配合使用的抑病效果及协同抑病机理;拮抗菌对采前田间和采后贮藏环境条件的适应能力;以及采前应用拮抗菌对果实采后贮藏期间病害的生物防治效力。研究结果表明： 　　1、酵母拮抗菌Cryptococcus laurentii与低浓度化学杀菌剂imazalil（25g/ml）和kresoxim-methyl（50g/ml）配合使用可以显著提高对冬枣果实采后黑霉病（Alternaria alternata）和褐腐病（Monilinia fructicola）的防治效果，杀菌剂并不影响拮抗菌在冬枣果实伤口的生长动态。 　　2、酵母拮抗菌Pichia membranefaciens和C. laurentii 与钼酸铵（NH4-Mo，5 mmol/L）和碳酸氢钠（NaHCO3，2%）配合能够显著提高对甜樱桃果实采后褐腐病（M. fructicola）的抑病能力。通过in vitro和扫描电镜观察结果表明，NH4-Mo和NaHCO3能够显著地抑制病原菌M. fructicola在培养基和果实伤口的生长，具有杀菌作用。 　　3、酵母拮抗菌C. laurentii和Rhodotorula glutinis与硅酸钠（Na2SiO3）配合使用对甜樱桃果实采后青霉病（Penicillium expansum）和褐腐病（M. fructicola）以及对冬枣果实青霉病（P. expansum）和黑霉病（A. alternata）的防治效果更好。经in vitro和扫描电镜观察表明，Na2SiO3对病原菌在培养基和果实伤口的生长有明显的抑制作用。同时，Na2SiO3还能诱导果实苯丙氨酸解氨酶（PAL）、多酚氧化酶（PPO）和过氧化物酶（POD）等抗性相关酶活性的提高。 　　4、酵母拮抗菌R. glutinis与水杨酸（SA，0.5mmol/L）配合可显著提高对甜樱桃果实采后青霉病（P. expansum）和黑霉病（A. alternata）的抑病能力。SA不影响拮抗菌在果实伤口的生长，in vitro实验中低浓度的SA对病原菌孢子萌发和芽管伸长也没有抑制作用。SA可能是通过诱导果实产生抗性来协同提高拮抗菌的抑病效果，而不是直接抑制病原菌生长。 　　5、酵母拮抗菌C. laurentii和R. glutinis在气调（Controlled atmospheres, CA）贮藏条件下对樱桃果实采后青霉病（P. expansum）和黑霉病（A. alternata）的防治效果显著提高。气调贮藏不抑制拮抗菌在甜樱桃果实伤口的生长。 　　6、采前应用酵母拮抗菌C. laurentii 和R. glutinis能够显著抑制甜樱桃果实在采后不同贮藏环境下的发病率。拮抗菌能够在田间果实表面生长并一直保持较高的数量。在试验的三种酵母拮抗菌中，C. laurentii的防病效果最好，该菌不仅能在果实表面迅速生长，也能适应低温和CA贮藏环境。"

酵母拮抗菌的抑病效力、规模化培养及相关机理研究

我们实验室从果实表面分离获得的酵母拮抗菌已经证明能有效防治各种果实采后主要病害，为了加快生物拮抗菌的商业化应用，本文在完善拮抗菌抑病机理的基础上，重点研究了拮抗菌规模化培养条件，生物菌剂制品的稳定性，以及拮抗菌对环境胁迫的生理反应。主要研究内容包括：（1）分析酵母菌拮抗菌、病原菌与果实之间的互作效应及其影响因子;（2）筛选酵母拮抗菌规模化培养的最佳营养配方及培养条件;（3）优化酵母拮抗菌干粉与液体剂型的制备方式;（4）研究酵母拮抗菌在不同剂型中生活力下降的可能机理;（5）探讨酵母拮抗菌次生代谢产物的抑菌效果。研究结果如下： 1、单独接种Monilinia fructicola或同时接种M. fructicola和Cryptococcus laurentii均能诱导甜樱桃果实SOD、CAT和POD等抗氧化酶活性升高并加速脂质过氧化，同时伴有PPO同工酶新酶带出现。病原菌M. fructicola和Penicillum expansum在接种初期均显著促进拮抗菌C. laurentii在桃果实伤口处的生长。C. laurentii在接种24h内显著抑制桃果实LOX活性、O2•-产生与H2O2积累。单独接种病原菌能显著诱导桃果实LOX活性升高，促进O2•-产生，但抑制H2O2积累。病菌侵染后果实中 O2•-增加，以及H2O2的降低可能是桃果实对病原菌侵染的一种生理应答方式。 2、抗坏血酸钠能显著提高C. laurentii对甜樱桃果实褐腐病的防治效果，较低浓度的拮抗菌（ 1×107 cells mL-1）与200mM抗坏血酸配合使用可以达到较高浓度拮抗菌（1×108 cells mL-1）单独使用对M. fructicola的防治效果。抗坏血酸钠的协同抑病机理可能是在抑制病原菌生长的同时，也抑制了果实的抗氧化酶活性，从而加速了脂质过氧化过程。 3、酵母菌产业化培养条件的筛选结果表明，不同拮抗菌对培养基中营养物质的需求不一样，培养所需的温度有差异。在120L发酵罐的中试实验表明两种拮抗菌采用筛选出的最佳培养条件均得到浓度大于1× 109 CFU mL-1的菌悬液。 4、保护剂种类是影响Rhodotorula glutinis 和 C. laurentii两种酵母拮抗菌冷冻干燥效果的最主要因素，但保护剂效果的发挥依赖于其浓度与酵母菌生长阶段。无菌水和PBS（100mM, pH5.8）可以作为拮抗菌C. laurentii液体剂型的有效保护剂，而柠檬酸钠（100mM, pH5.8）则诱导拮抗菌C. laurentii的生活力快速丧失。 5、酵母菌拮抗菌冻干制品的研究表明，在胁迫环境下酵母菌生活力快速丧失与大量产生活性氧有关，这暗示活性氧的产生可能是导致酵母菌细胞死亡的主要因素。柠檬酸钠（100mM, pH5.8）对C. laurntii死亡的诱导效应受柠檬酸根浓度和介质酸度的双重影响。活性氧在柠檬酸钠诱导酵母菌生活力快速丧失中大量产生并发挥重要作用。 6、酵母拮抗菌能够产生某些对果实采后病原真菌具有抑制效果的挥发性和不挥发性物质。同一种酵母菌产生的物质对不同病原菌有不同的拮抗效果，而不同酵母菌对同一种病原菌的拮抗效果也不完全相同。但是，不同类型的培养基对拮抗菌产生的抑菌物质有明显的影响。

海藻糖提高酵母拮抗菌生活力和生防效力的作用机制

近年来，利用酵母拮抗菌进行果实采后病害的生物防治已经成为果实采后领域的研究热点。但是，在实际应用中生物拮抗菌制剂的防病效果远不如化学药剂稳定。由于生物拮抗菌是活体，生活力和生防效力易受诸多因素影响。在商品化制剂的剂型加工、销售、以及使用过程中的环境条件往往影响酵母拮抗菌的生活力和抑病能力，成为酵母拮抗菌产业化生产和商品化应用过程中的一个主要障碍。将酵母拮抗菌和其它化学物质配合使用可以提高拮抗菌的生防效力。另外，增加酵母拮抗菌对逆境条件的耐受力也是增加或稳定其防治效果的有效途径。本文研究了海藻糖与酵母拮抗菌生活力和生防效力的关系，通过生理手段提高了酵母拮抗菌内源海藻糖的含量，同时探讨了在多种逆境条件下内源海藻糖含量对酵母拮抗菌生活力和生防效力的影响及其作用机制。主要研究结果如下： 1. 以1 %海藻糖作为碳源培养酵母拮抗菌Cryptococcus laurentii可以提高其内源海藻糖含量。在in vitro试验中，提高内源海藻糖含量可以提高C. laurentii在低温（1 ºC）、气调（1 ºC，5 % O2，5 % CO2）条件下的生活力;在in vivo试验中，提高C. laurentii内源海藻糖含量可以提高其在苹果果实伤口上的种群密度和对苹果青霉病的防治效果。内源海藻糖的积累还能提高C. laurentii冷冻干燥后的生活力，海藻糖对酵母细胞质膜的保护作用可能是一个主要原因。 2. 以1 %海藻糖作为碳源能提高酵母拮抗菌Rhodotorula glutinis的内源海藻糖含量。内源海藻糖含量的增加可以提高C. laurentii和R. glutinis在慢速冷冻处理中的生活力。同时，海藻糖作为外源保护剂可以明显提高两种酵母拮抗菌在冷冻干燥处理后的生活力。在快速冷冻、慢速冷冻和冷冻干燥处理中，提高酵母拮抗菌的内源海藻糖含量并使用海藻糖作为外源保护剂可以获得更高的生活力。同时，这种内、外源保护因子的综合作用也可以提高两种拮抗菌在苹果果实伤口上的种群密度和对苹果青霉病的防治效果。 3. 脱脂牛奶和糖（葡萄糖，半乳糖，蔗糖，海藻糖）作为保护剂可以提高C. laurentii冷冻干燥后在常温（25 ºC）和低温（4 ºC）保存过程中的生活力。脱脂牛奶和糖保护剂的复合使用对C. laurentii的保护效果高于其单独使用的效果。通过对几种常用的碳源进行筛选，发现柠檬酸作为碳源对C. laurentii内源海藻糖的积累有明显的诱导作用。当使用相同的保护剂或保护剂组合时，高内源海藻糖含量的酵母拮抗菌生活力更强。当冷冻干燥前使用半乳糖 + 脱脂牛奶作为保护剂时，高内源海藻糖含量的C. laurentii在4 ºC保存90 天后对苹果青霉病的防治效果和与新鲜培养的酵母拮抗菌相当。 4. 酵母拮抗菌C. laurentii冷冻干燥后在常温(25 ºC)保存期间，细胞生活力下降，细胞膜的完整性降低，胞内活性氧水平增加，同时与抗氧化相关的超氧化物歧化酶（SOD）活性也增加，而过氧化氢酶（CAT）活性则下降。提高内源海藻糖含量和/或使用外源保护剂（5 %脱脂牛奶 + 10 %葡萄糖）可以减缓上述指标下降或上升的速度。内、外源因子的共同作用有利于提高对拮抗菌细胞的保护作用。 5. 利用褐藻酸钠制成的含酵母拮抗菌的胶球在干燥后能有效的保持C. laurentii的生活力。在3种不同粘度的褐藻酸钠中，0.5 % 3500 cp的褐藻酸钠表现出较好的保护效果。内源海藻糖的积累可以提高干胶球中C. laurentii的生活力，作为外源保护剂的4种糖（葡萄糖、半乳糖、蔗糖、海藻糖）中只有海藻糖在低温条件下可以提高C. laurentii的生活力，其它3种糖反而降低了C. laurentii的生活力。

外源物质对酵母拮抗菌生活力的影响

　　近年来，酵母拮抗菌在水果采后病害防治中展示了良好的应用前景。然而，在实际应用中,酵母拮抗菌在逆境条件下会因为发生凋亡或细胞损伤而引起生活力的下降，最终导致拮抗菌抑病能力降低。研究酵母拮抗菌生活力下降的规律，提高酵母拮抗菌的生产效率，减少剂型加工过程中的细胞损伤，增强其对逆境条件的耐受力是增加或稳定生防制剂防治效果的有效途径。本文主要研究酵母拮抗菌正常培养过程中生活力下降的规律，筛选剂型加工过程中对酵母拮抗菌具有保护作用的化学物质，并对酵母拮抗菌的培养条件进行了优化。主要研究结果如下： 　　1. 在正常培养过程中，酵母拮抗菌Rhodotorula glutinis和Cryptococcus laurentii中细胞染色质凝集或细胞膜破损的发生一般在6天以后。外源加入的N-乙酰半胱氨酸及硅酸钠等物质在超过一定浓度时会加速酵母菌的死亡。 　　2. 在不同的液体悬浮制剂中，对R. glutinis而言，使用磷酸缓冲液（PBS）悬浮时保护效果最好；而C. laurentii悬浮在NYDB培养基中或海藻糖、乳糖溶液中时的生活力最高。 　　3. 以10 %葡萄糖 + 5 %脱脂牛奶作保护剂，可以有效地保持酵母拮抗菌C. laurentii冻干制剂的生活力，配合使用的保护效果高于它们单独使用时的保护效果。添加1 mM N-乙酰半胱氨酸能更好地保持拮抗菌制剂在常温保存过程中的生活力，这可能与这种还原性物质缓解了细胞内活性氧的积累有关。 　　4. 不同酵母拮抗菌对不同碳、氮源的利用能力有明显差异。在9种不同的碳源和10种不同的氮源中，Pichia membranefaciens能够最有效利用的碳、氮源是葡萄糖、果糖和多价胨，而Candida guilliermondii的最佳碳源和氮源分别是果糖和肉蛋白胨。

Antagonistic interactions between garden yeasts and microfungal garden pathogens of leaf-cutting ants

We investigate the diversity of yeasts isolated in gardens of the leafcutter ant Atta texana. Repeated sampling of gardens from four nests over a 1-year time period showed that gardens contain a diverse assemblage of yeasts. The yeast community in gardens consisted mostly of yeasts associated with plants or soil, but community composition changed between sampling periods. In order to understand the potential disease-suppressing roles of the garden yeasts, we screened isolates for antagonistic effects against known microfungal garden contaminants. In vitro assays revealed that yeasts inhibited the mycelial growth of two strains of Escovopsis (a specialized attine garden parasite), Syncephalastrum racemosum (a fungus often growing in gardens of leafcutter lab nests), and the insect pathogen Beauveria bassiana. These garden yeasts add to the growing list of disease-suppressing microbes in attine nests that may contribute synergistically, together with actinomycetes and Burkholderia bacteria, to protect the gardens and the ants against diseases. Additionally, we suggest that garden immunity against problem fungi may therefore derive not only from the presence of disease-suppressing Pseudonocardia actinomycetes, but from an enrichment of multiple disease-suppressing microorganisms in the garden matrix.

A fission yeast homolog of Int-6, the mammalian oncoprotein and eIF3 subunit, induces drug resistance when overexpressed

Through a screen to identify genes that induce multi-drug resistance when overexpressed, we have identified a fission yeast homolog of Int-6, a component of the human translation initiation factor eIF3. Disruption of the murine Int-6 gene by mouse mammary tumor virus (MMTV) has been implicated previously in tumorigenesis, although the underlying mechanism is not yet understood. Fission yeast Int6 was shown to interact with other presumptive components of eIF3 in vivo, and was present in size fractions consistent with its incorporation into a 43S translation preinitiation complex. Drug resistance induced by Int6 overexpression was dependent on the AP-1 transcription factor Pap1, and was associated with increased abundance of Pap1-responsive mRNAs, but not with Pap1 relocalization. Fission yeast cells lacking the int6 gene grew slowly. This growth retardation could be corrected by the expression of full length Int6 of fission yeast or human origin, or by a C-terminal fragment of the fission yeast protein that also conferred drug resistance, but not by truncated human Int-6 proteins corresponding to the predicted products of MMTV-disrupted murine alleles. Studies in fission yeast may therefore help to explain the ways in which Int-6 function can be perturbed during MMTV-induced mammary tumorigenesis.

Molecular basis for lysine specificity in the yeast ubiquitin-conjugating enzyme Cdc34

Ubiquitin (Ub)-conjugating enzymes (E2s) and ubiquitin ligases (E3s) catalyze the attachment of Ub to lysine residues in substrates and Ub during monoubiquitination and polyubiquitination. Lysine selection is important for the generation of diverse substrate-Ub structures, which provides versatility to this pathway in the targeting of proteins to different fates. The mechanisms of lysine selection remain poorly understood, with previous studies suggesting that the ubiquitination site(s) is selected by the E2/E3-mediated positioning of a lysine(s) toward the E2/E3 active site. By studying the polyubiquitination of Sic1 by the E2 protein Cdc34 and the RING E3 Skp1/Cul1/F-box (SCF) protein, we now demonstrate that in addition to E2/E3-mediated positioning, proximal amino acids surrounding the lysine residues in Sic1 and Ub are critical for ubiquitination. This mechanism is linked to key residues composing the catalytic core of Cdc34 and independent of SCF. Changes to these core residues altered the lysine preference of Cdc34 and specified whether this enzyme monoubiquitinated or polyubiquitinated Sic1. These new findings indicate that compatibility between amino acids surrounding acceptor lysine residues and key amino acids in the catalytic core of ubiquitin-conjugating enzymes is an important mechanism for lysine selection during ubiquitination.

The role of the yeast cleavage and polyadenylation factor subunit Ydh1p/Cft2p in pre-mRNA 3'-end formation

Cleavage and polyadenylation factor (CPF) is a multi‐protein complex that functions in pre‐mRNA 3′‐end formation and in the RNA polymerase II (RNAP II) transcription cycle. Ydh1p/Cft2p is an essential component of CPF but its precise role in 3′‐end processing remained unclear. We found that mutations in YDH1 inhibited both the cleavage and the polyadenylation steps of the 3′‐end formation reaction in vitro. Recently, we demonstrated that an important function of CPF lies in the recognition of poly(A) site sequences and RNA binding analyses suggesting that Ydh1p/Cft2p interacts with the poly(A) site region. Here we show that mutant ydh1 strains are deficient in the recognition of the ACT1 cleavage site in vivo. The C‐terminal domain (CTD) of RNAP II plays a major role in coupling 3′‐end processing and transcription. We provide evidence that Ydh1p/Cft2p interacts with the CTD of RNAP II, several other subunits of CPF and with Pcf11p, a component of CF IA. We propose that Ydh1p/Cft2p contributes to the formation of important interaction surfaces that mediate the dynamic association of CPF with RNAP II, the recognition of poly(A) site sequences and the assembly of the polyadenylation machinery on the RNA substrate.

Independent functions of yeast Pcf11p in pre-mRNA 3' end processing and in transcription termination

Pcf11p, an essential subunit of the yeast cleavage factor IA, is required for pre‐mRNA 3′ end processing, binds to the C‐terminal domain (CTD) of the largest subunit of RNA polymerase II (RNAP II) and is involved in transcription termination. We show that the conserved CTD interaction domain (CID) of Pcf11p is essential for cell viability. Interestingly, the CTD binding and 3′ end processing activities of Pcf11p can be functionally uncoupled from each other and provided by distinct Pcf11p fragments in trans. Impaired CTD binding did not affect the 3′ end processing activity of Pcf11p and a deficiency of Pcf11p in 3′ end processing did not prevent CTD binding. Transcriptional run‐on analysis with the CYC1 gene revealed that loss of cleavage activity did not correlate with a defect in transcription termination, whereas loss of CTD binding did. We conclude that Pcf11p is a bifunctional protein and that transcript cleavage is not an obligatory step prior to RNAP II termination.

Immunization of male rabbits with sheep luteal receptor to LH results in production of antibodies exhibiting hormone-agonistic and -antagonistic activities

Antibodies to LH/chorionic gonadotrophin receptor (LH/CG-R; molecular weight 67 000), isolated in a homogenous state (established by SDS-PAGE and ligand blotting) from sheep luteal membrane using human CG (hCG)-Sepharose affinity chromatography, were raised in three adult male rabbits (R-I, R-II and R-III). Each of the rabbits received 20-30 mu g oi the purified receptor in Freund's complete adjuvant at a time. Primary immunization was followed by booster injection at intervals. Production of receptor antibodies was monitored by (1) determining the dilution of the serum (IgG fraction) that could specifically bind 50% of I-125-LH/CG-R added and (2) analysing sera for any chance in testosterone levels. Following primary immunization and the first booster, all three rabbits exhibited a 2.5- to 6.0-fold increase in serum testosterone over basal levels and this effect was spread over a period of time (similar to 40 days) coinciding with the rise and fall of receptor antibodies. The maximal antibody titre (ED(50)) produced at this time ranged from 1:350 to 1:100 to below detectable limits for R-I, R-II and R-III respectively. Subsequent immunizations followed by the second booster resulted in a substantial increase in antibody titre (ED(50) of 1:5000) in R-I, but this was not accompanied by any change in serum testosterone over preimmune levels, suggesting that with the progress of immunization the character of the antibody produced had also changed. Two pools of antisera from R-I collected 10 days following the booster (at day 70 (bleed I) and day 290 (bleed II)) were used in further experiments. IgG isolated from bleed I but not from bleed II antiserum showed a dose-dependent stimulation of testosterone production by mouse Leydig cells in vitro, thus confirming the in vivo hormone-mimicking activity antibodies generated during the early immunization phase. The IgG fractions from both bleeds were, however, capable of inhibiting (1) I-125-hCG binding to crude sheep luteal membrane (EC(50) of 1:70 and 1:350 for bleed I and II antisera respectively) and (2) ovine LH-stimulated testosterone production by mouse Leydig cells in vitro, indicating the presence oi antagonistic antibodies irrespective of the period of time during which the rabbits were immunized. The: fact that bleed I-stimulated testosterone production could be inhibited in a dose-dependent manner by the addition of IgG from bleed II to the mouse Leydig cell in vitro assay system showed that the agonistic activity is intrinsic to the bleed I antibody. The receptor antibody (bleed II) was also capable of blocking LH action in vivo, as rabbits passively (for 24 h with LH/CG-R antiserum) as well as actively (for 130 days) immunized against LH/CG-R failed to respond to a bolus injection of LH (50 mu g). At no time, however, was the serum testosterone reduced below the basal level. This study clearly shows that, unlike with LH antibody, attempts to achieve an LH deficiency effect in vivo by resorting to immunization with hole LH receptor is difficult, as receptor antibodies exhibit both hormone-mimicking (agonistic) as well as hormone-blocking (antagonistic) activities.

The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities

Developing novel drugs against the unicellular parasite Plasmodium is complicated by the paucity of simple screening systems. Heat-shock proteins are an essential class of proteins for the parasite's cyclical life style between different cellular milieus and temperatures. The molecular chaperone Hsp90 assists a large variety of proteins, but its supporting functions for many proteins that are important for cancer have made it into a well-studied drug target. With a better understanding of the differences between Hsp90 of the malarial parasite and Hsp90 of its human host, new therapeutic options might become available. We have generated a set of isogenic strains of the budding yeast Saccharomyces cerevisiae where the essential yeast Hsp90 proteins have been replaced with either of the two human cytosolic isoforms Hsp90 alpha or Hsp90 beta, or with Hsp90 from Plasmodium falciparum (Pf). All strains express large amounts of the Flag-tagged Hsp90 proteins and are viable. Even though the strain with Pf Hsp90 grows more poorly, it provides a tool to reconstitute additional aspects of the parasite Hsp90 complex and its interactions with substrates in yeast as a living test tube. Upon exposure of the set of Hsp90 test strains to the two Hsp90 inhibitors radicicol (Rd) and geldanamycin (GA), we found that the strain with Pf Hsp90 is relatively more sensitive to GA than to Rd compared to the strains with human Hsp90's. This indicates that this set of yeast strains could be used to screen for new Pf Hsp90 inhibitors with a wider therapeutic window.